Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir/Ritonavir Switch Study on Endothelial Function in HIV
NCT00312754Phase 4Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Jun 2005; status: terminated.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00312754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312754.